Originally Hosted: April 6, 2021
Duration: 15 Minutes

Check out Cryoport’s Company Presentation from the 2021 Cell & Gene Meeting on the Med. Cryoport Systems CEO Mark Sawicki, Ph.D. discusses how the first-ever guidance for the transportation of cell and gene therapies supports the standardization of regenerative medicine supply chains. Dr. Sawicki also covers how Cryoport Systems adheres to the standard and the company's upcoming new technologies that will directly support de-risking the regenerative medicine supply chain.

Watch the video on-demand here:

Meeting on the Med 2021

 

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC